#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	16120	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2391	815.8	0	.	n	.	0	C1450T	SNP	1450	1450	C	1754	1754	T	1018	T,G,A	1014,2,2	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	16120	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2391	815.8	1	SNP	n	C1184T	0	.	.	1184	1184	C	1488	1488	C	1029	C,T	1028,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27742	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4158	831.5	0	.	n	.	0	T695C	SNP	695	695	T	1282	1282	C	995	C,T,G	992,1,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27742	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4158	831.5	0	.	n	.	0	A1638G	SNP	1638	1638	A	2225	2225	G	1042	G,T,C	1037,3,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27742	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4158	831.5	0	.	n	.	0	T1971C	SNP	1971	1971	T	2558	2558	C	984	C,T,G	981,1,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27742	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4158	831.5	1	SNP	n	A2045G	0	.	.	2045	2045	A	2632	2632	A	952	A,T	950,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27742	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4158	831.5	1	SNP	n	C2597T	0	.	.	2597	2597	C	3184	3184	C	953	C,T,A	947,2,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_F_01537c	folP.WHO_F_01537c	1	1	27	2416	folP	852	852	100.0	folP.l15.c4.ctg.1	2067	145.8	1	SNP	p	R228S	0	.	.	682	684	CGC	1289	1291	CGC	210;206;204	C;G,A;C	210;205,1;204	folP.WHO_F_01537c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5508	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	4044	169.6	1	SNP	p	S91F	0	.	.	271	273	TCC	797	799	TCC	187;185;184	T;C,G;C,T	187;184,1;183,1	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5508	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	4044	169.6	1	SNP	p	D95N	0	.	.	283	285	GAC	809	811	GAC	194;197;197	G;A,G,C;C	194;195,1,1;197	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5508	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	4044	169.6	1	SNP	p	D95G	0	.	.	283	285	GAC	809	811	GAC	194;197;197	G;A,G,C;C	194;195,1,1;197	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_M_01390	mtrR.WHO_M_01390	1	1	27	2178	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	2023	134.2	1	SNP	p	G45D	1	.	.	133	135	GAC	780	782	GAC	224;223;223	G;A;C	224;223;223	mtrR.WHO_M_01390:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1130	mtrR_promoter	250	250	99.2	mtrR_promoter.l15.c4.ctg.1	1538	91.6	0	.	n	.	0	T10C	SNP	10	10	T	619	619	C	188	C,A,T	185,2,1	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1130	mtrR_promoter	250	250	99.2	mtrR_promoter.l15.c4.ctg.1	1538	91.6	0	.	n	.	0	A197.	DEL	197	197	A	805	805	A	229	A	229	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5074	parC	2304	2304	99.7	parC.l6.c17.ctg.1	3526	179.6	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1940	1942	GCA	246;246;245	G;C;A	246;246;245	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5074	parC	2304	2304	99.7	parC.l6.c17.ctg.1	3526	179.6	0	.	p	.	0	V596I	NONSYN	1786	1788	GTT	2423	2425	ATT	239;239;240	A,T;T,A;T,G	238,1;238,1;239,1	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5074	parC	2304	2304	99.7	parC.l6.c17.ctg.1	3526	179.6	1	SNP	p	D86N	0	.	.	256	258	GAC	893	895	GAC	212;214;214	G;A;C	212;214;214	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5074	parC	2304	2304	99.7	parC.l6.c17.ctg.1	3526	179.6	1	SNP	p	S87R	0	.	.	259	261	AGT	896	898	AGT	216;217;219	A;G;T	216;217;219	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5074	parC	2304	2304	99.7	parC.l6.c17.ctg.1	3526	179.6	1	SNP	p	S87W	0	.	.	259	261	AGT	896	898	AGT	216;217;219	A;G;T	216;217;219	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5074	parC	2304	2304	99.7	parC.l6.c17.ctg.1	3526	179.6	1	SNP	p	S87I	0	.	.	259	261	AGT	896	898	AGT	216;217;219	A;G;T	216;217;219	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5074	parC	2304	2304	99.7	parC.l6.c17.ctg.1	3526	179.6	1	SNP	p	S88P	0	.	.	262	264	TCC	899	901	TCC	221;222;224	T;C;C	221;222;224	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4666	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3143	185.1	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1832	1834	GGC	267;266;265	G;G;C	266;265;264	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.22.001	penA.22.001	1	1	27	4892	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2866	212.4	1	SNP	p	A311V	0	.	.	931	933	GCA	1452	1454	GCA	272;271;270	G;C;A,T	272;271;269,1	penA.22.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4892	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2866	212.4	1	SNP	p	I312M	0	.	.	934	936	ATC	1455	1457	ATC	271;273;273	A;T,A;C	271;272,1;273	penA.22.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4892	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2866	212.4	1	SNP	p	V316P	0	.	.	946	948	GTG	1467	1469	GTG	283;281;282	G;T;G,A,T,C	283;281;278,2,1,1	penA.22.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4892	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2866	212.4	1	SNP	p	V316T	0	.	.	946	948	GTG	1467	1469	GTG	283;281;282	G;T;G,A,T,C	283;281;278,2,1,1	penA.22.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4892	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2866	212.4	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1971	1973	ACC	293;295;295	A,T,C;C,T;C,T	291,1,1;293,2;294,1	penA.22.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4892	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2866	212.4	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2025	2027	GCG	288;288;288	G;C;G,T,C	288;288;286,1,1	penA.22.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4892	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2866	212.4	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2025	2027	GCG	288;288;288	G;C;G,T,C	288;288;286,1,1	penA.22.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4892	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2866	212.4	1	SNP	p	G543S	0	.	.	1627	1629	GGT	2148	2150	GGT	263;263;265	G,A;G,A;T,G,C	262,1;262,1;263,1,1	penA.22.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4892	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2866	212.4	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2157	2159	GGC	265;264;263	G;G,T,A;C	265;262,1,1;263	penA.22.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4892	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2866	212.4	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2175	2177	CCG	277;277;276	C;C,T;G,C	277;276,1;275,1	penA.22.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6160	ponA	2397	2397	100.0	ponA.l6.c4.ctg.1	3650	210.3	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1962	1964	CCG	268;268;267	C,G,A;C,G;G	266,1,1;267,1;267	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2814	porA	1146	1146	99.65	porA.l15.c4.ctg.1	2342	149.7	0	.	p	.	0	S22G	NONSYN	64	66	AGC	692	694	GGC	216;214;213	G,A;G;C	215,1;214;213	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2814	porA	1146	1146	99.65	porA.l15.c4.ctg.1	2342	149.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	874	874	C	196	C	196	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	27	3348	porB1b	1047	1047	100.0	porB1b.l6.c4.ctg.1	2229	187.2	1	SNP	p	G120K	0	.	.	358	360	GGC	1005	1007	GGC	260;261;257	G;G,C;C,G	260;260,1;256,1	porB1b.WHO_P_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	27	3348	porB1b	1047	1047	100.0	porB1b.l6.c4.ctg.1	2229	187.2	1	SNP	p	A121D	1	.	.	361	363	GAC	1008	1010	GAC	257;258;258	G,C;A;C	256,1;258;258	porB1b.WHO_P_02204c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	27	3348	porB1b	1047	1047	100.0	porB1b.l6.c4.ctg.1	2229	187.2	1	SNP	p	D121N	0	.	.	361	363	GAC	1008	1010	GAC	257;258;258	G,C;A;C	256,1;258;258	porB1b.WHO_P_02204c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	11298	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	5465	257.8	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2320	2322	CAT	293;292;290	C,G;A;T	292,1;292;290	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1588	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1665	118.9	1	SNP	p	V57M	1	.	.	169	171	ATG	822	824	ATG	293;294;293	A,G,C;T;G	291,1,1;294;293	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
